Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INSCI CORP | 1,288,926 | reported | 05 Dec 2003 | tx 2+567,127 |
| Lifeward Ltd. | 361,682 | reported | 16 Aug 2016 | tx 7−31,928 |
| ENTHRUST FINANCIAL SERVICES INC | 110,000 | reported | 02 Jul 2012 | tx 16+309,968 |
| Vector Intersect Security Acquisition Corp. | 57,500 | reported | 15 Feb 2015 | tx 40+1,347,613−592,617 |
| Baudax Bio, Inc. | 46,820 | reported | 15 Jun 2022 | tx 11+413,283 |
| AUXILIUM PHARMACEUTICALS INC | 15,000 | reported | 13 Jun 2007 | tx 24+3,565,428−18,779,691 |
| INNOVATIVE SOLUTIONS & SUPPORT INC | 9,523 | reported | 13 Jun 2023 | tx 42+162,493−222,980 |
| AMKOR TECHNOLOGY, INC. | 2,613 | reported | 13 May 2026 | tx 408+975,517.49−745,924.897 |
| GRIFFIN LAND & NURSERIES INC | 1,274 | reported | 12 May 2015 | tx 35+42,914−75,840 |
| Recro Pharma, Inc. | 0 | reported | 08 Apr 2024 | tx 44+3,793,597−2,393,618 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 May 2026 | EXERCISE | AMKOR TECHNOLOGY, INC. | 9,893 | 0.00 USD | |
| 13 May 2026 | EXERCISE | AMKOR TECHNOLOGY, INC. | 9,893.057 | 0.00 USD | deriv |
| 13 May 2026 | GRANT_AWARD | AMKOR TECHNOLOGY, INC. | 2,613 | 0.00 USD | deriv |
| 05 May 2026 | SALE | AMKOR TECHNOLOGY, INC. | 7,000 | 76.45 USD | |
| 23 Dec 2025 | GRANT_AWARD | AMKOR TECHNOLOGY, INC. | 20.01 | 0.00 USD | deriv |
| 15 Dec 2025 | SALE | AMKOR TECHNOLOGY, INC. | 5,000 | 44.29 USD | |
| 15 Dec 2025 | EXERCISE | AMKOR TECHNOLOGY, INC. | 5,000 | 19.39 USD | |
| 15 Dec 2025 | EXERCISE | AMKOR TECHNOLOGY, INC. | 5,000 | 0.00 USD | deriv |
| 23 Sept 2025 | GRANT_AWARD | AMKOR TECHNOLOGY, INC. | 27.36 | 0.00 USD | deriv |
| 25 Jun 2025 | GRANT_AWARD | AMKOR TECHNOLOGY, INC. | 38.53 | 0.00 USD | deriv |
| 14 May 2025 | EXERCISE | AMKOR TECHNOLOGY, INC. | 6,017 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | AMKOR TECHNOLOGY, INC. | 9,789 | 0.00 USD | deriv |
| 14 May 2025 | EXERCISE | AMKOR TECHNOLOGY, INC. | 6,017.03 | 0.00 USD | deriv |
| 02 Apr 2025 | GRANT_AWARD | AMKOR TECHNOLOGY, INC. | 25.99 | 0.00 USD | deriv |
| 23 Dec 2024 | GRANT_AWARD | AMKOR TECHNOLOGY, INC. | 108.8 | 0.00 USD | deriv |
| 23 Sept 2024 | GRANT_AWARD | AMKOR TECHNOLOGY, INC. | 14.86 | 0.00 USD | deriv |
| 27 Aug 2024 | EXERCISE | AMKOR TECHNOLOGY, INC. | 20,000 | 11.71 USD | |
| 27 Aug 2024 | SALE | AMKOR TECHNOLOGY, INC. | 20,000 | 32.97 USD | |
| 27 Aug 2024 | EXERCISE | AMKOR TECHNOLOGY, INC. | 20,000 | 0.00 USD | deriv |
| 24 Jun 2024 | GRANT_AWARD | AMKOR TECHNOLOGY, INC. | 12.38 | 0.00 USD | deriv |
| 14 May 2024 | EXERCISE | AMKOR TECHNOLOGY, INC. | 8,571 | 0.00 USD | |
| 14 May 2024 | GRANT_AWARD | AMKOR TECHNOLOGY, INC. | 5,855 | 0.00 USD | deriv |
| 14 May 2024 | EXERCISE | AMKOR TECHNOLOGY, INC. | 8,571.04 | 0.00 USD | deriv |
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 73,620 | 1.10 USD | |
| 08 Apr 2024 | TENDER | Recro Pharma, Inc. | 227,982 | 1.10 USD |
6 purchases reported after at least 12 months of silence — most recent on 28 Aug 2023.